Predictmedix launches its COVID-19 screening technology in healthcare
TORONTO, ON / ACCESSWIRE / May 6, 2020 / Predictmedix Inc. (CSE:PMED)(OTCQB:PMEDF) (“Predictmedix” or the “Company”) is pleased to announce that the company has begun deployment of its artificial intelligence (“AI”) technology for mass screening of COVID-19 with Max Healthcare. Max Healthcare is one of the largest healthcare groups in South Asia, encompassing 14 hospitals with over 3000 doctors.
COVID-19 has emerged as one of the biggest burdens for healthcare and the identification and tracking of an outbreak is a critical element of controlling the spread across geographical areas. Healthcare facilities tend to be the prime places where an outbreak can occur and with a large movement of people in such places, mass screening technologies are needed to help mitigate the risk of further spread. The current deployment is for no financial consideration at the time and both parties have conducted their due diligence.
“Screening stations in airports, shopping malls and staff entrances to hospitals etc. are based on questionnaires. Screening questionnaires are ineffective because they depend on honest and accurate answers from people that are either unaware or unforthcoming of their symptoms. The process is potentially harmful because the screening itself causes a bottleneck of foot traffic and the accumulation of people in proximity, creating the potential for disease transmission. AI powered cameras in airports, travel hubs and staff entrances of hospitals and factories etc. could divert infected individuals to self isolation and treatment while allowing healthy individuals to proceed unimpeded.” said Dr. Alexander Bardon, an Emergency Medicine physician in Ontario and an advisor to Predictmedix.
“Deployment of our COVID-19 AI screening technology with one of the largest healthcare groups in South Asia is a testament to the need for our technology and is a major step towards the global launch of our technology”, said Dr. Rahul Kushwah, COO of Predictmedix.
Predictmedix has developed a proprietary technology (patent pending) to screen for potential cases of COVID-19 and other related infectious diseases. The AI powered technology utilizes multispectral imaging with a focus on visual spectral imaging along with infrared thermography to identify cases which are suspected of COVID-19. The technology can be deployed using multispectral cameras in facilities where there is large movement of people to identify potential COVID-19 cases and limit exposure, thereby limiting infection. The data collected is brought into a central server / cloud for analysis and alerts are sent in case of a positive detection to the surveillance department within the facility where the technology is deployed within seconds.
Disclaimer: “The Company is not making any express or implied claims that its mass screening product has the ability to eliminate, cure or contain the Covid-19 (or SARS-2 Coronavirus) at this time”.
For more details on this release please click on the following video interview;
About Max Healthcare
Max Healthcare is one of South Asia’s leading comprehensive provider of standardized, seamless and international-class healthcare services. It is committed to the highest standards of medical and service excellence, patient care, scientific and medical education. Max Healthcare has 14 hospitals in India, offering services in over 30 medical disciplines. Max Healthcare has a base of over 3,000 doctors, 10,000 employees and over 2.2 million patients from over 80 countries, across its network of 14 hospitals.
Max Healthcare is controlled by Max Group. The Max Group is a leading Indian multi-business conglomerate with a commanding presence in the Life Insurance and Healthcare industry. It has ventured into high potential sectors – Senior Living and Real Estate. In FY2019, the Group recorded consolidated revenue of approximately $4 billion CAD. It has a total customer base of 11 million, over 350 offices spread across India and employee strength of more than 27,500 as on 31st March 2019. The Group’s investor base includes marquee global financial institutions such as New York Life, KKR, IFC Washington, Vanguard, Ward Ferry, Briarwood Capital, Nomura, Aberdeen, First State Investments, First Voyager, Eastspring, Target Asset Management, Baron, Jupiter and Doric Capital.